United Kingdom · Funded startup

Who invested in NeoVac

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 31 Oct 2026

$23Mraised across 1 round since 2025, from 1 source

Latest round
Round, $23MSept 2025
Investors
0
See who backed them

The rounds

  1. Sept 2025
    Round$23M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

Funding filed with regulators

NeoVac filed 2 raises, $23M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Nov 2025$1000KUK share allotment
  2. Sept 2025$22MUK share allotment

Founders and team

From NeoVac's own website: 1 on the team.

  • Prof. Dan PeerChairperson

AdvisersProf. Adrian Hill

Also claim to have backed them

This firm lists NeoVac as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Future Planet CapitalVC firmPre-seed, per its site

Quick answers about NeoVac

How much has NeoVac raised?

NeoVac has raised $23M across 1 round since 2025.

When did NeoVac last raise?

NeoVac's most recent round, $23M, was in Sept 2025.

What was NeoVac's biggest round?

Its most recent round, $23M in Sept 2025, is also its largest on record.

Where is NeoVac based?

NeoVac is based in the United Kingdom.

Companies like NeoVac

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.